JP2013535445A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535445A5 JP2013535445A5 JP2013520241A JP2013520241A JP2013535445A5 JP 2013535445 A5 JP2013535445 A5 JP 2013535445A5 JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013520241 A JP2013520241 A JP 2013520241A JP 2013535445 A5 JP2013535445 A5 JP 2013535445A5
- Authority
- JP
- Japan
- Prior art keywords
- activation
- antibody against
- pharmaceutical composition
- enhancing antibody
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130353 | 2010-07-21 | ||
| RU2010130353/15A RU2542445C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
| RU2011127058/15A RU2536232C2 (ru) | 2011-07-01 | 2011-07-01 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
| RU2011127058 | 2011-07-01 | ||
| PCT/IB2011/002434 WO2012010978A2 (en) | 2010-07-21 | 2011-07-15 | A method of treating alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535445A JP2013535445A (ja) | 2013-09-12 |
| JP2013535445A5 true JP2013535445A5 (enExample) | 2014-04-24 |
Family
ID=44863153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520241A Pending JP2013535445A (ja) | 2010-07-21 | 2011-07-15 | アルツハイマー病を治療する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20130058982A1 (enExample) |
| EP (1) | EP2596021A2 (enExample) |
| JP (1) | JP2013535445A (enExample) |
| CN (1) | CN103119060A (enExample) |
| AU (1) | AU2011281252A1 (enExample) |
| CA (1) | CA2805943A1 (enExample) |
| DE (1) | DE112011102409T5 (enExample) |
| EA (1) | EA029399B1 (enExample) |
| FR (1) | FR2962912A1 (enExample) |
| GB (1) | GB2496801B (enExample) |
| IT (1) | ITTO20110633A1 (enExample) |
| MX (1) | MX2013000808A (enExample) |
| NZ (1) | NZ606969A (enExample) |
| PH (1) | PH12013500143A1 (enExample) |
| UA (1) | UA107836C2 (enExample) |
| WO (1) | WO2012010978A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| KR20140014059A (ko) * | 2010-07-15 | 2014-02-05 | 올레그 일리치 엡쉬테인 | 활성화되고 강화된 형태의 항체의 효과를 증가시키는 방법 |
| BR112013000841A2 (pt) | 2010-07-15 | 2016-06-07 | Oleg Lliich Epshtein | composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano. |
| CN103154028A (zh) | 2010-07-15 | 2013-06-12 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物以及对神经退行性疾病相关的疾病或病症进行治疗的方法 |
| PH12013500141A1 (en) * | 2010-07-21 | 2013-03-11 | Oleg Lliich Epshtein | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| CA2805963A1 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| CN104324359B (zh) * | 2014-09-25 | 2016-08-17 | 中山大学 | Rry三肽在制备治疗阿尔茨海默症药物中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2156621C1 (ru) | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| AU2002258518A1 (en) * | 2001-03-14 | 2002-09-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| US6451547B1 (en) * | 2001-04-25 | 2002-09-17 | Syn X Pharma | Process for differential diagnosis of Alzheimer's dementia and device therefor |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| EP1594447A2 (en) * | 2002-10-02 | 2005-11-16 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| GB2414670B (en) | 2003-03-14 | 2008-03-19 | Nutrition Res Inc | Homeopathic formulations useful for treating pain and/or inflammation |
| BRPI0601496B8 (pt) * | 2006-04-13 | 2021-05-25 | Miria De Amorim | composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas |
| PH12013500141A1 (en) * | 2010-07-21 | 2013-03-11 | Oleg Lliich Epshtein | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
-
2011
- 2011-07-15 US US13/135,892 patent/US20130058982A1/en not_active Abandoned
- 2011-07-15 EP EP11775840.9A patent/EP2596021A2/en not_active Ceased
- 2011-07-15 EA EA201300130A patent/EA029399B1/ru not_active IP Right Cessation
- 2011-07-15 WO PCT/IB2011/002434 patent/WO2012010978A2/en not_active Ceased
- 2011-07-15 UA UAA201300104A patent/UA107836C2/uk unknown
- 2011-07-15 MX MX2013000808A patent/MX2013000808A/es not_active Application Discontinuation
- 2011-07-15 PH PH1/2013/500143A patent/PH12013500143A1/en unknown
- 2011-07-15 JP JP2013520241A patent/JP2013535445A/ja active Pending
- 2011-07-15 AU AU2011281252A patent/AU2011281252A1/en not_active Abandoned
- 2011-07-15 CA CA2805943A patent/CA2805943A1/en not_active Abandoned
- 2011-07-15 IT IT000633A patent/ITTO20110633A1/it unknown
- 2011-07-15 GB GB1302929.3A patent/GB2496801B/en not_active Expired - Fee Related
- 2011-07-15 FR FR1156479A patent/FR2962912A1/fr not_active Withdrawn
- 2011-07-15 NZ NZ606969A patent/NZ606969A/en not_active IP Right Cessation
- 2011-07-15 CN CN2011800454649A patent/CN103119060A/zh active Pending
- 2011-07-15 DE DE112011102409T patent/DE112011102409T5/de not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535445A5 (enExample) | ||
| JP2013536174A5 (enExample) | ||
| JP2013535444A5 (enExample) | ||
| JP2013535436A5 (enExample) | ||
| CY1120637T1 (el) | Πολυπεπτιδικα αντισωματα που ανταγωνιζονται cd40 | |
| HK1210792A1 (en) | Molecules with antigen binding and polyvalent fc gamma receptor binding activity | |
| JP2013537532A5 (enExample) | ||
| UA112743C2 (uk) | Терапевтичний dll4-зв'язувальний білок | |
| EA201391719A1 (ru) | Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| JP2013533269A5 (enExample) | ||
| EA201170357A1 (ru) | Инженерные антитела к il-13: композиции, способы и применение | |
| EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
| PH12016500859A1 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
| WO2017194782A3 (en) | Therapeutic targeting of non-cellular structures | |
| DOP2011000189A (es) | Proteinas de enlace de miostatina | |
| WO2013120012A3 (en) | Cdim binding proteins and uses thereof | |
| AR082245A1 (es) | Composicion farmaceutica de combinacion para tratar enfermedades funcionales o condiciones de tracto gastrointestinal | |
| HRP20200936T1 (hr) | Antitijela za beta amiloid | |
| CL2007003635A1 (es) | Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer. | |
| UA116194C2 (uk) | Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном | |
| PH12013501636A1 (en) | Treatment of osteoarthritis and pain | |
| JO3462B1 (ar) | أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها | |
| WO2013059559A3 (en) | Compounds and methods for enhancing innate immune responses | |
| UA112755C2 (uk) | Метод лікування синдрому дефіциту уваги і гіперактивності |